Testing effectiveness (Phase 2)Study completedNCT00237172
What this trial is testing
Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)
Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 72